메뉴 건너뛰기




Volumn 257, Issue 6, 2010, Pages 964-968

T1ρ and T2ρ MRI in the evaluation of parkinson's disease

Author keywords

Biomarker; High field MRI; Iron; Magnetic resonance imaging; Parkinson's disease

Indexed keywords

ADULT; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MAMMILLARY BODY; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PRIORITY JOURNAL; RED NUCLEUS; RIGIDITY; SUBSTANTIA NIGRA; TREMOR; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DYSKINESIA; EVALUATION; HEMISPHERIC DOMINANCE; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; VALIDATION STUDY;

EID: 77954427526     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5446-2     Document Type: Article
Times cited : (64)

References (29)
  • 2
    • 0042433192 scopus 로고    scopus 로고
    • Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
    • BA Faucheux ME Martin C Beaumont JJ Hauw Y Agid EC Hirsch 2003 Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease J Neurochem 86 5 1142 1148 1:CAS:528:DC%2BD3sXmvFait7Y%3D 12911622 (Pubitemid 37022190)
    • (2003) Journal of Neurochemistry , vol.86 , Issue.5 , pp. 1142-1148
    • Faucheux, B.A.1    Martin, M.-E.2    Beaumont, C.3    Hauw, J.-J.4    Agid, Y.5    Hirsch, E.C.6
  • 3
    • 59249090537 scopus 로고    scopus 로고
    • Glutathione depletion in immortalized midbrain-derived dopaminergeric neurons results in increases in the labile iron pool: Implications for Parkinson's disease
    • 10.1016/j.freeradbiomed.2008.11.012 1:CAS:528:DC%2BD1MXhs1ejs7k%3D 19118623
    • D Kaur D Lee S Ragapolan JK Andersen 2009 Glutathione depletion in immortalized midbrain-derived dopaminergeric neurons results in increases in the labile iron pool: implications for Parkinson's disease Free Radic Biol Med 46 5 593 598 10.1016/j.freeradbiomed.2008.11.012 1:CAS:528:DC%2BD1MXhs1ejs7k%3D 19118623
    • (2009) Free Radic Biol Med , vol.46 , Issue.5 , pp. 593-598
    • Kaur, D.1    Lee, D.2    Ragapolan, S.3    Andersen, J.K.4
  • 4
    • 48749123360 scopus 로고    scopus 로고
    • Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease
    • 1:CAS:528:DC%2BD1cXhtVegtLjK 18624918
    • L Zecca L Casella A Albertini C Bellei FA Zucca M Engelen, et al.. 2008 Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease J Neurochem 106 4 1866 1875 1:CAS:528:DC%2BD1cXhtVegtLjK 18624918
    • (2008) J Neurochem , vol.106 , Issue.4 , pp. 1866-1875
    • Zecca, L.1    Casella, L.2    Albertini, A.3    Bellei, C.4    Zucca, F.A.5    Engelen, M.6
  • 5
    • 53749096620 scopus 로고    scopus 로고
    • Genetics of iron regulation and the possible role of iron in Parkinson's disease
    • 10.1016/j.nbd.2008.07.001 1:CAS:528:DC%2BD1cXht1Kns7nO 18675357
    • SL Rhodes B Ritz 2008 Genetics of iron regulation and the possible role of iron in Parkinson's disease Neurobiol Dis 32 2 183 195 10.1016/j.nbd.2008.07. 001 1:CAS:528:DC%2BD1cXht1Kns7nO 18675357
    • (2008) Neurobiol Dis , vol.32 , Issue.2 , pp. 183-195
    • Rhodes, S.L.1    Ritz, B.2
  • 6
    • 57449092273 scopus 로고    scopus 로고
    • Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease
    • 10.1073/pnas.0804373105 1:CAS:528:DC%2BD1cXhsVOltLzN 19011085
    • J Salazar N Mena S Hunot A Prigent D Alvarez-Fischer M Arrendondo, et al.. 2008 Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease Proc Natl Acad Sci USA 105 47 18578 18583 10.1073/pnas.0804373105 1:CAS:528:DC%2BD1cXhsVOltLzN 19011085
    • (2008) Proc Natl Acad Sci USA , vol.105 , Issue.47 , pp. 18578-18583
    • Salazar, J.1    Mena, N.2    Hunot, S.3    Prigent, A.4    Alvarez-Fischer, D.5    Arrendondo, M.6
  • 7
    • 57049088549 scopus 로고    scopus 로고
    • Detection of Parkinson's disease by MRI: Spin-lattice distribution imaging
    • 10.1002/mds.22210 18759364
    • M Hutchinson U Raff 2008 Detection of Parkinson's disease by MRI: Spin-lattice distribution imaging Mov Disord 23 14 1991 1997 10.1002/mds.22210 18759364
    • (2008) Mov Disord , vol.23 , Issue.14 , pp. 1991-1997
    • Hutchinson, M.1    Raff, U.2
  • 8
    • 34147107527 scopus 로고    scopus 로고
    • Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts
    • DOI 10.1002/mds.21227
    • S Michaeli G Oz DJ Sorce M Garwood K Ugurbil S Majestic, et al.. 2007 Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts Mov Disord 22 3 334 340 10.1002/mds.21227 17149719 (Pubitemid 46569686)
    • (2007) Movement Disorders , vol.22 , Issue.3 , pp. 334-340
    • Michaeli, S.1    Oz, G.2    Sorce, D.J.3    Garwood, M.4    Ugurbil, K.5    Majestic, S.6    Tuite, P.7
  • 9
    • 0028998624 scopus 로고
    • Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease
    • 1:STN:280:DyaK2MzgtlaktA%3D%3D 7783878
    • JM Gorell RJ Ordidge GG Brown JC Deniau NM Buderer JA Helpern 1995 Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease Neurology 45 6 1138 1143 1:STN:280:DyaK2MzgtlaktA%3D%3D 7783878
    • (1995) Neurology , vol.45 , Issue.6 , pp. 1138-1143
    • Gorell, J.M.1    Ordidge, R.J.2    Brown, G.G.3    Deniau, J.C.4    Buderer, N.M.5    Helpern, J.A.6
  • 10
    • 42049123661 scopus 로고    scopus 로고
    • Midbrain iron content in early Parkinson disease: A potential biomarker of disease status
    • DOI 10.1212/01.wnl.0000286384.31050.b5, PII 0000611420080415100008
    • WR Martin M Wieler M Gee 2008 Midbrain iron content in early Parkinson disease: a potential biomarker of disease status Neurology 70 16 1411 1417 10.1212/01.wnl.0000286384.31050.b5 1:CAS:528:DC%2BD1cXksFantr8%3D 18172063 (Pubitemid 351521933)
    • (2008) Neurology , vol.70 , Issue.16 PART 2 , pp. 1411-1417
    • Martin, W.R.W.1    Wieler, M.2    Gee, M.3
  • 11
  • 12
    • 0032937059 scopus 로고    scopus 로고
    • Diagnostic criteria for Parkinson disease
    • DOI 10.1001/archneur.56.1.33
    • D Gelb E Oliver S Gilman 1999 Diagnostic criteria for Parkinson disease Arch Neurol 56 1 33 39 10.1001/archneur.56.1.33 1:STN:280:DyaK1M7itVKgtg%3D%3D 9923759 (Pubitemid 29046907)
    • (1999) Archives of Neurology , vol.56 , Issue.1 , pp. 33-39
    • Gelb, D.J.1    Oliver, E.2    Gilman, S.3
  • 13
    • 0000224448 scopus 로고
    • Unified Parkinson's disease rating scale
    • members of the UPDRS Development Committee Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Florham Park
    • Fahn S, Elton RL, members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson's disease. Macmillan Healthcare Information, Florham Park, pp 153-163
    • (1987) Recent Developments in Parkinson's Disease. Macmillan Healthcare Information , pp. 153-163
    • Fahn, S.1    Elton, R.L.2
  • 14
    • 0016823810 scopus 로고
    • "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
    • 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D 1202204
    • M Folstein S Folstein PR McHugh 1975 "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 3 189 198 10.1016/0022-3956(75)90026-6 1:STN:280: DyaE28%2FntFKjtw%3D%3D 1202204
    • (1975) J Psychiatr Res , vol.12 , Issue.3 , pp. 189-198
    • Folstein, M.1    Folstein, S.2    McHugh, P.R.3
  • 16
    • 0025213880 scopus 로고
    • Applications to T1, T2, and chemical-shift imaging
    • 10.1002/mrm.1910130109
    • A Haase Snapshot FLASH MRI 1990 Applications to T1, T2, and chemical-shift imaging Magn Reson Med 13 1 77 89 10.1002/mrm.1910130109
    • (1990) Magn Reson Med , vol.13 , Issue.1 , pp. 77-89
    • Haase Snapshot, A.1    Flash, M.2
  • 17
    • 0021769485 scopus 로고
    • Selective population inversion in NMR
    • 10.1038/310681a0 1:STN:280:DyaL2c3psFGksw%3D%3D 6472448
    • MS Silver RI Joseph CN Chen VJ Sank DI Hoult 1984 Selective population inversion in NMR Nature 310 5979 681 683 10.1038/310681a0 1:STN:280: DyaL2c3psFGksw%3D%3D 6472448
    • (1984) Nature , vol.310 , Issue.5979 , pp. 681-683
    • Silver, M.S.1    Joseph, R.I.2    Chen, C.N.3    Sank, V.J.4    Hoult, D.I.5
  • 18
    • 0032816549 scopus 로고    scopus 로고
    • The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
    • DOI 10.1093/brain/122.8.1437
    • P Damier E Hirsch Y Agid A Graybiel 1999 The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease Brain 122 1437 1448 10.1093/brain/122.8.1437 10430830 (Pubitemid 29374122)
    • (1999) Brain , vol.122 , Issue.8 , pp. 1437-1448
    • Damier, P.1    Hirsch, E.C.2    Agid, Y.3    Graybiel, A.M.4
  • 19
    • 43649084042 scopus 로고    scopus 로고
    • Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
    • DOI 10.1016/j.bandc.2007.10.002, PII S0278262607001637
    • ER Foster KJ Black JA Antenor-Dorsey JS Perlmutter T Hershey 2008 Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson's disease Brain Cogn 67 1 1 10 10.1016/j.bandc.2007.10. 002 18022303 (Pubitemid 351685743)
    • (2008) Brain and Cognition , vol.67 , Issue.1 , pp. 1-10
    • Foster, E.R.1    Black, K.J.2    Antenor-Dorsey, J.A.V.3    Perlmutter, J.S.4    Hershey, T.5
  • 21
    • 0023804321 scopus 로고
    • Increased iron (III) and total iron content in postmortem substantia nigra of parkinsonian brain
    • 10.1007/BF01244786 1:STN:280:DyaL1M%2FpsVegsQ%3D%3D 3210014
    • E Sofic P Riederer H Heinsen H Beckmann GP Reynolds G Hebenstreit, et al.. 1988 Increased iron (III) and total iron content in postmortem substantia nigra of parkinsonian brain J Neural Transm 74 3 199 205 10.1007/BF01244786 1:STN:280:DyaL1M%2FpsVegsQ%3D%3D 3210014
    • (1988) J Neural Transm , vol.74 , Issue.3 , pp. 199-205
    • Sofic, E.1    Riederer, P.2    Heinsen, H.3    Beckmann, H.4    Reynolds, G.P.5    Hebenstreit, G.6
  • 22
    • 0345425800 scopus 로고    scopus 로고
    • 1 in the rotating frame
    • DOI 10.1002/(SICI)1522-2594(199908)42:2<268::AID-MRM8>3.0.CO;2-A
    • OH Grohn JA Lukkarinen MJ Silvennoinen A Pitkanen PC van Zijl RA Kauppinen 1999 Quantitative magnetic resonance imaging assessment of cerebral ischemia in rat using on-resonance T(1) in the rotating frame Magn Reson Med 42 2 268 276 10.1002/(SICI)1522-2594(199908)42:2<268::AID-MRM8>3.0.CO;2-A 1:STN:280:DyaK1MzntVeltA%3D%3D 10440951 (Pubitemid 29364705)
    • (1999) Magnetic Resonance in Medicine , vol.42 , Issue.2 , pp. 268-276
    • Grohn, O.H.J.1    Lukkarinen, J.A.2    Silvennoinen, M.J.3    Pitkanen, A.4    Van Zijl, P.C.M.5    Kauppinen, R.A.6
  • 24
  • 26
    • 18144397394 scopus 로고    scopus 로고
    • Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease
    • DOI 10.1002/mds.20311
    • D Berg B Merz K Reiners M Naumann G Becker 2005 Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease Mov Disord 20 3 383 385 10.1002/mds.20311 15486999 (Pubitemid 40613305)
    • (2005) Movement Disorders , vol.20 , Issue.3 , pp. 383-385
    • Berg, D.1    Merz, B.2    Reiners, K.3    Naumann, M.4    Becker, G.5
  • 27
    • 0025695511 scopus 로고
    • The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease
    • 1:STN:280:DyaK3M%2FmvFejtw%3D%3D 2123623
    • KL Leenders EP Salmon P Tyrrell D Perani DJ Brooks H Sager, et al.. 1990 The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease Arch Neurol 47 12 1290 1298 1:STN:280:DyaK3M%2FmvFejtw%3D%3D 2123623
    • (1990) Arch Neurol , vol.47 , Issue.12 , pp. 1290-1298
    • Leenders, K.L.1    Salmon, E.P.2    Tyrrell, P.3    Perani, D.4    Brooks, D.J.5    Sager, H.6
  • 28
    • 1342326304 scopus 로고    scopus 로고
    • Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT
    • DOI 10.1002/mds.10531
    • W Pirker I Holler W Gerschlager S Asenbaum G Zettinig T Brucke 2003 Measuring the rate of progression of Parkinson's disease over a 5-year periods with beta-CIT SPECT Mov Disord 18 11 1266 1272 10.1002/mds.10531 14639666 (Pubitemid 38263309)
    • (2003) Movement Disorders , vol.18 , Issue.11 , pp. 1266-1272
    • Pirker, W.1    Holler, I.2    Gerschlager, W.3    Asenbaum, S.4    Zettinig, G.5    Brucke, T.6
  • 29
    • 0033910602 scopus 로고    scopus 로고
    • 123I-FP-CIT SPECT striatal uptake
    • DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V
    • HT Benamer J Patterson DJ Wyper DM Hadley GJ Macphee DG Grosset 2000 Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake Mov Disord 15 4 692 698 10.1002/1531-8257(200007)15:4<692:: AID-MDS1014>3.0.CO;2-V 1:STN:280:DC%2BD3M%2FotlWqsg%3D%3D 10928580 (Pubitemid 30479622)
    • (2000) Movement Disorders , vol.15 , Issue.4 , pp. 692-698
    • Benamer, H.T.S.1    Patterson, J.2    Wyper, D.J.3    Hadley, D.M.4    Macphee, G.J.A.5    Grosset, D.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.